After the cytotoxicity of MEK162 combined with BKM120 on a first-generation EGFR-TKI resistant NSCLC cell line was confirmed, our next study focused on analyzing the effect of the drug on the cell signal transduction pathway, rather than on the expression of apoptotic effector molecules. Here, EGFR is linked to non-small cell lung carcinoma.